RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
DI PERRI G
Collezione ASL Città di Torino
Items : 172
Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical Trial. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):180-191. doi: 10.1097/QAI.0000000000003480.
2024
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Trentalange A; Giaccone C; Trunfio M; Noce G; Ghisetti V; Tettoni MC; Nigra M; Guastamacchia G; Stroffolini G; Pirriatore V; Barco A; Vai D; Lazzaro A;
Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study. in AIDS and behavior / AIDS Behav. 2024 Nov;28(11):3643-3654. doi: 10.1007/s10461-024-04440-w. Epub 2024 Jul 30.
2024
ASL Città di Torino
Vai D; Bonora S; Di Perri G; Calcagno A; Letendre SL; Cinnirella G; Imperiale D; Quarta C; Trunfio M; Vuaran E; Di Stefano A;
Intrathecal production of anti-Epstein-Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIV. in AIDS (London, England) / AIDS. 2024 Mar 15;38(4):477-486. doi: 10.1097/QAD.0000000000003775. Epub 2023 Nov 7.
2024
AOU Città della Salute di Torino
ASL Città di Torino
Letendre SL; Calcagno A; Di Perri G; Cavallo R; Bonora S; Imperiale D; Croce M; Pittaluga F; Vai D; Trunfio M; Sacchi A;
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Jun;63(6):107137. doi: 10.1016/j.ijantimicag.2024.107137. Epub 2024 Ma
2024
AOU Città della Salute di Torino
ASL Città di Torino
Calcagno A; D'Avolio A; Di Perri G; Trunfio M; Marinaro L; Bonora S; Avataneo V; Mula J; Antonucci M; Cusato J; Manca A; Palermiti A;
Central Nervous System Disorders with Auto-Antibodies in People Living with HIV. in Microorganisms / Microorganisms. 2024 Aug 24;12(9):1758. doi: 10.3390/microorganisms12091758.
2024
ASL Città di Torino
Calcagno A; Trunfio M; Di Perri G; Imperiale D; Stroffolini G; Atzori C;
Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual Therapy. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2024 Apr 26;13(5):518. doi: 10.3390/antiox13050518.
2024
ASL Città di Torino
D'Avolio A; Di Perri G; Lupo C; Rainoldi A; Bonora S; Cuomo S; Trevisan G; Maddalone MG; Tettoni MC; Mula J; Bianco G; Chiara F; Accardo G; Palermiti A; Manca A; Antonucci M; Ferrara M; Cusato J; Mulasso A;
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infections. in The Journal of infection / J Infect. 2023 Nov;87(5):462-464. doi: 10.1016/j.jinf.2023.03.013. Epub 2023 Mar 17.
2023
ASL Città di Torino
ASL Asti
Penna D; Piccioni P; Venuti F; Botto C; Trezzi M; Betti M; Sestini S; Erba PA; Lupia T; Di Perri G; Aliberti S; Calcagno A; Stroffolini G; Gaviraghi A;
COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2023 May 20;12(5):1133. doi: 10.3390/antiox12051133.
2023
ASL Città di Torino
Calcagno A; D'Avolio A; Bonora S; Di Perri G; Maiese D; Ferrara M; Antonucci M; Chiara F; De Vivo ED; Costanzo M; Cusato J; Manca A; Mula J; Palermiti A;
COVID-19: A Possible Contribution of the MAPK Pathway. in Biomedicines / Biomedicines. 2023 May 16;11(5):1459. doi: 10.3390/biomedicines11051459.
2023
ASL Città di Torino
Calcagno A; D'Avolio A; De Rosa FG; Di Perri G; Ferrara M; De Vivo ED; Ianniello A; Chiara F; Corcione S; Antonucci M; Trunfio M; Costanzo M; Palermiti A; Mula J; Cusato J; Manca A;
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman. in Virology journal / Virol J. 2023 Jun 13;20(1):123. doi: 10.1186/s12985-023-02086-z.
2023
ASL Città di Torino
Bonora S; Calcagno A; Alladio F; Fantino S; Di Perri G; Burdino E; Allice T; Longo BM; Di Girolamo L; Ferrara M; Trevisan G;
Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Jun;18(1-2):169-182. doi: 10.1007/s11481-023-10066-x. Epub 2023 May 11
2023
ASL Città di Torino
Di Perri G; Bonora S; Guastamacchia G; Nigra M; Napoli L; Atzori C; Trunfio M; Mighetto L; Calcagno A;
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2023 Jan 12;13(2):295. doi: 10.3390/diagnostics13020295.
2023
ASL Città di Torino
Mula J; Bonora S; D'Avolio A; Calcagno A; Di Perri G; Manca A; Palermiti A; Marinaro L; Trunfio M; Cusato J; Avataneo V; Antonucci M;
Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood-brain barrier, beta amyloid, and tau proteins in people living with HIV. in Journal of neurovirology / J Neurovirol. 2023 Feb;29(1):100-105. doi: 10.1007/s13365-022-01105-z. Epub 2022 Nov 9.
2023
ASL Città di Torino
Calcagno A; Di Perri G; Atzori C; Russo M; Burdino E; Imperiale D; Ponzetta L; Trunfio M; Di Girolamo L;
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Dec;18(4):551-562. doi: 10.1007/s11481-023-10086-7. Epub 2023 Oct 31.
2023
ASL Città di Torino
Calcagno A; Atzori C; Trunfio M; Di Perri G G; Bonora S; Barco A; Pirriatore V; Nigra M; Giaccone C; Vai D; Stroffolini G; Lazzaro A;
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants in Diagnostics
2023
ASL Città di Torino
Palermiti A; Manca A; Di Perri G; Mula J; Bonora S; D’Avolio A; Calcagno A; Cusato J; Avataneo V; Antonucci M; Trunfio M; Marinaro L;
NEUROCOGNITIVE IMPAIRMENT NEGATIVELY AFFECTS VIRAL CONTROL IN ART-TREATED PWH in Topics in Antiviral Medicine
2023
ASL Città di Torino
Trunfio M; Vuaran E; Vai D; Di Stefano A; Imperiale D; Bonora S; Di Perri G; Calcagno A;
THE CEREBROSPINAL FLUID VIROME IN VIRALLY SUPPRESSED PEOPLE LIVING WITH HIV in Topics in Antiviral Medicine
2023
ASL Città di Torino
Trunfio M; Fox V; Scutari R; Fini V; Granaglia A; Russo C; Vuaran E; Imperiale D; Perno CF; Bonora S; Di Perri G; Alteri C; Calcagno A;
Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia. in Lung / Lung. 2022 Oct;200(5):573-577. doi: 10.1007/s00408-022-00566-7. Epub 2022 Sep 17.
2022
ASL Città di Torino
Bonora S; Di Perri G; Trunfio M; Cortese G; Traverso F; Nespoli P; Vicinanza S; Portesani F; Calcagno A;
Trichinella britovi outbreak in Piedmont, North-West Italy, 2019-2020: Clinical and epidemiological insights in the one health perspective. in Travel medicine and infectious disease / Travel Med Infect Dis. 2022 May-Jun;47:102308. doi: 10.1016/j.tmaid.2022.102308. Epub 2022 Mar 9.
2022
ASL Città di Torino
ASL Asti
ASL Torino 4
ASL Torino 3
Di Perri G; Calleri G; Calcagno A; Bonora S; Lipani F; Paltrinieri G; Lupia T; Faraoni S; Stroffolini G; Rossi L;
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano
Calcagno A; Rosa FG; Di Perri G; Chiara F; Antonucci M; De Nicolò A; Allegra S; De Francia S; Palermiti A; Mula J; Manca A; Cusato J; D'Avolio A;
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355.
2022
ASL Città di Torino
Smedile A; D'Avolio A; Cantù M; Di Perri G; Saracco GM; Cariti G; Manca A; Mula J; Antonucci M; Ciancio A; Palermiti A; Avataneo V; Troshina G; Caviglia GP; Mornese Pinna S; De Nicolò A; Boglione L; Cusato J;
Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options. in Microorganisms / Microorganisms. 2022 Jun 23;10(7):1275. doi: 10.3390/microorganisms10071275.
2022
ASL Città di Torino
AOU Città della Salute di Torino
Calcagno A; Di Perri G; Bonora S; Rugge W; Scabini S; Trunfio M;
Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV. in AIDS and behavior / AIDS Behav. 2022 Jul;26(7):2203-2211. doi: 10.1007/s10461-021-03563-8. Epub 2022 Jan 4.
2022
ASL Città di Torino
Calcagno A; Bonora S; Di Perri G; Imperiale D; Domini S; Alcantarini C; Trunfio M; Milesi M; Medina C; Vai D; De Francesco D;
Wastewater-based SARS-CoV-2 environmental monitoring for Piedmont, Italy. in Environmental research / Environ Res. 2022 Jan;203:111901. doi: 10.1016/j.envres.2021.111901. Epub 2021 Aug 19.
2022
ARPA Piemonte
ASL Città di Torino
ASL Torino 4
Di Perri G; Cusato J; Civra A; Polato D; Brizio E; Quaglino P; Lembo D; Robotto A;
Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy. in Annals of work exposures and health / Ann Work Expo Health. 2022 Feb 18;66(2):224-232. doi: 10.1093/annweh/wxab062.
2022
ASL Vercelli
ASL Città di Torino
Faggiano F; Vineis P; Patrucco F; Trunfio M; Gallo L; Locana E; Valinotto R; Di Perri G; Calcagno A; Airoldi C;
Obstetric and neonatal outcomes after SARS-CoV-2 infection in the first trimester of pregnancy: A prospective comparative study. in The journal of obstetrics and gynaecology research / J Obstet Gynaecol Res. 2022 Feb;48(2):393-401. doi: 10.1111/jog.15105. Epub 2021 Nov 23.
2022
AOU Città della Salute di Torino
ASL Città di Torino
Benedetto C; Di Perri G; Mengozzi G; Ghisetti V; Mazzone R; Bevilacqua F; Bovetti M; Bertero L; Borella F; Cusato J; Carosso AR; Cosma S;
Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2022 Aug;32(8):1936-1943. doi: 10.1016/j.numecd.2022.05.004. Epub 2022 Ma
2022
ASL Città di Torino
AOU Città della Salute di Torino
Ghigo E; Di Perri G; Bonora S; Trentini L; Mazzetti R; Pusterla A; Maiorino F; Bioletto F; Massano M; Barale M; Procopio M;
Patterns of Cerebrospinal Fluid Alzheimer's Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition. in Viruses / Viruses. 2022 Apr 4;14(4):753. doi: 10.3390/v14040753.
2022
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Vai D; Nigra M; Imperiale D; Di Stefano A; Atzori C; Pasquero M; Trunfio M;
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2022 Apr 28:1-3. doi: 10.1080/1120009X.2022.2068850.
2022
ASL Città di Torino
Boni S; Antonucci M; Manca A; Nicolò A; Martinelli L; Artioli S; Pacini G; Di Perri G; D'Avolio A;
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders. in Journal of neurovirology / J Neurovirol. 2022 Apr;28(2):226-235. doi: 10.1007/s13365-021-01047-y. Epub 2022 Jan 19.
2022
ASL Città di Torino
Di Perri G; Calcagno A; Noce G; Atzori C; Trunfio M; Bonora S; Guastamacchia G; Lazzaro A; Vai D; Pirriatore V; Barco A; Orlando S; Stroffolini G;
Parietal intrahemispheric source connectivity of resting-state electroencephalographic alpha rhythms is abnormal in Naïve HIV patients. in Brain research bulletin / Brain Res Bull. 2022 Apr;181:129-143. doi: 10.1016/j.brainresbull.2022.01.015. Epub 2022 Jan 29.
2022
ASL Città di Torino
Babiloni C; Del Percio C; Lizio R; Lopez S; Pennica A; Roma P; Correr V; Cucciolla F; Toma G; Soricelli A; Di Campli F; Aceti A; Teti E; Sarmati L; Crocetti G; Ferri R; Lorenzo I; Galli M; Negri C; Angarano G; Saracino A; Lepore L; Di Pietro M; Fusco FM; Vullo V; D'Ettorre G; Pagliano P; Di Flumeri G; Celesia BM; et alii...
The importance of Therapeutic Drug Monitoring during pregnancy in a HIV-positive woman taking lifelong antiretroviral therapy in Biochimica Clinica
2022
ASL Città di Torino
Cusato J; D'Avolio A; Di Perri G; Bonora S; Calcagno A; Antonucci M; Marinaro L;
2022
ASL Città di Torino
Guastamacchia G; Bonora S; Di Perri G; Calcagno A; Trunfio M; Mighetto L; Napoli L; Atzori C; Nigra M;
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants in Pharmaceuticals
2022
ASL Città di Torino
Mula J; Antonucci M; De Nicolò A; Allegra S; De Francia S; Chiara F; Di Perri G; De Rosa FG; Calcagno A; Cusato J; Palermiti A; Manca A; D’avolio A;
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases. in Frontiers in microbiology / Front Microbiol. 2022 Apr 1;13:829393. doi: 10.3389/fmicb.2022.829393. eCollection 2022.
2022
ASL Città di Torino
Venuti F; Ghisetti V; Longo B; Staffilano E; Alladio F; Trunfio M; Richiardi L; Burdino E; Bonora S; Vineis P; Di Perri G; Calcagno A;
BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors. in Le infezioni in medicina / Infez Med. 2022 Jun 1;30(2):242-246. doi: 10.53854/liim-3002-9. eCollection 2022.
2022
ASL Città di Torino
Di Perri G; Calcagno A; Bonora S; Lupia T; Bonfanti P; Lapadula G; Barco A; Rossi M; De Benedetto I;
Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study. in Therapie / Therapie. 2021 Sep-Oct;76(5):409-414. doi: 10.1016/j.therap.2020.10.003. Epub 2020 Oct 23.
2021
ASL Città di Torino
AOU Città della Salute di Torino
De Rosa FG; D'Avolio A; Romeo MR; Di Perri G; Stella M; Corgiat Loia R; Corcione S; De Nicolò A; Lupia T; Segala FV; Pensa A;
Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring. in Biomedicines / Biomedicines. 2021 Sep 12;9(9):1202. doi: 10.3390/biomedicines9091202.
2021
ASL Città di Torino
Di Perri G; De Nicolò A; D'Avolio A; Calcagno A; Ianniello A; De Vivo ED; Avataneo V; Cusato J; Mula J; Antonucci M; Manca A; Palermiti A;
Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz. in Nutrients / Nutrients. 2021 Oct 12;13(10):3571. doi: 10.3390/nu13103571.
2021
ASL Città di Torino
Calcagno A; Tempestilli M; Cusato J; Vergori A; Piselli P; Antonucci M; Avataneo V; Palermiti A; Notari S; Antinori A; Di Perri G; Agrati C; D'Avolio A;
Alzheimer Dementia in People Living With HIV. in Neurology. Clinical practice / Neurol Clin Pract. 2021 Oct;11(5):e627-e633. doi: 10.1212/CPJ.0000000000001060.
2021
ASL Città di Torino
Gisslen M; Di Perri G; Guaraldi G; Arena V; d'Ettorre G; Imperiale D; Atzori C; Orofino G; Trunfio M; Celani L; Calcagno A;
Serology for Borrelia spp. in Northwest Italy: A Climate-Matched 10-Year Trend. in Life (Basel, Switzerland) / Life (Basel). 2021 Nov 27;11(12):1310. doi: 10.3390/life11121310.
2021
ASL Città di Torino
ASL Asti
Stroffolini G; Calcagno A; Di Perri G; De Rosa FG; Rossi L; Zanet S; Tomassone L; Lupia T; Faraoni S; Segala FV;
Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare Workers. in Vaccines / Vaccines (Basel). 2021 Nov 23;9(12):1377. doi: 10.3390/vaccines9121377.
2021
ASL Città di Torino
Bonora S; Calcagno A; Di Perri G; Emanuele T; Burdino E; Ghisetti V; Verga F; Trunfio M;
Low cerebrospinal fluid Amyloid-?eta 1-42 in patients with tuberculous meningitis. in BMC neurology / BMC Neurol. 2021 Nov 16;21(1):449. doi: 10.1186/s12883-021-02468-2.
2021
ASL Città di Torino
Calcagno A; Di Perri G; Trunfio M; Nigra M; Di Stefano A; Guastamacchia G; Atzori C; Audagnotto S; Stroffolini G;
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 13;14(5):460. doi: 10.3390/ph14050460.
2021
ASL Città di Torino
Ianniello A; Manca A; De Nicolò A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;
Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 May 12;11(5):867. doi: 10.3390/diagnostics11050867.
2021
ASL Città di Torino
Di Perri G; Calcagno A; Imperiale D; Bonora S; Atzori C; Nigra M; Cusato J; Ghisetti V; Trunfio M; Caligaris G;
Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV. in AIDS (London, England) / AIDS. 2021 May 1;35(6):939-945. doi: 10.1097/QAD.0000000000002853.
2021
ASL Città di Torino
Focà E; Calcagno A; Milic J; Calza S; Guaraldi G; Rota M; Renzetti S; Celotti A; Siano M; Celesia BM; Piconi S; de Socio GV; Cattelan AM; Orofino G; Riva A; Nozza S; di Perri G;
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe
2021
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Piccioni P; D'Avolio A; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Trentalange A; Motta I; Borgogno E;
Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers. in The Journal of steroid biochemistry and molecular biology / J Steroid Biochem Mol Biol. 2021 Jun;210:105854. doi: 10.1016/j.jsbmb.2021.105854. Epub 2021 Feb 22.
2021
AOU San Luigi di Orbassano
ASL Città di Torino
Leoni V; Poli G; Di Perri G; Lembo D; Biasi F; D'Avolio A; Cusato J; Civra A; Boglione L; Caccia C;
The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries. in Microorganisms / Microorganisms. 2021 Jul 31;9(8):1648. doi: 10.3390/microorganisms9081648.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Calcagno A; Castelnuovo B; Bonora S; Di Perri G; Pirriatore V; Alcantarini C; Rugge W; Mornese Pinna S; Scabini S; Trunfio M;
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases. in The Lancet. Infectious diseases / Lancet Infect Dis. 2021 Jul;21(7):914-915. doi: 10.1016/S1473-3099(21)00205-X. Epub 2021 Apr 14.
2021
ASL Città di Torino
Trunfio M; Calcagno A; Bonora S; Di Perri G;
Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26
2021
ASL Città di Torino
Di Perri G; D'Avolio A; Bonora S; de Nicolò A; Gervasoni C; Mistrangelo M; Testi R; Cattaneo D; Calcagno A; Dal Conte I;
The "scar" of a pandemic: Cumulative incidence of COVID-19 during the first trimester of pregnancy. in Journal of medical virology / J Med Virol. 2021 Jan;93(1):537-540. doi: 10.1002/jmv.26267. Epub 2020 Aug 13.
2021
AOU Città della Salute di Torino
ASL Città di Torino
Di Perri G; Katsaros D; Benedetto C; Mengozzi G; Preti M; Corcione S; Cusato J; Sciarrone A; Carosso A; Borella F; Cosma S;
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):103-109. doi: 10.1007/s40262-020-00916-9.
2021
ASL Città di Torino
Gervasoni C; Borghetti A; Moltó J; Calcagno A; Milesi M; Valle M; Avataneo V; Alcantarini C; Pla-Junca F; Trunfio M; D'Avolio A; Di Giambenedetto S; Cattaneo D; Di Perri G; Bonora S;
Prenatal Biochemical and Ultrasound Markers in COVID-19 Pregnant Patients: A Prospective Case-Control Study. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 Feb 26;11(3):398. doi: 10.3390/diagnostics11030398.
2021
ASL Città di Torino
Benedetto C; Di Perri G; Filippini C; Ghisetti V; Rolfo A; Revelli A; Marozio L; Sciarrone A; Gervasoni F; Bevilacqua F; Carosso M; Cusato J; Bovetti M; Borella F; Carosso AR; Cosma S;
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients. in Viruses / Viruses. 2021 Feb 11;13(2):281. doi: 10.3390/v13020281.
2021
ASL Città di Torino
Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A;
Co-infection with other respiratory pathogens in COVID-19 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2021 Feb;27(2):297-298. doi: 10.1016/j.cmi.2020.08.012. Epub 2020 Aug 19.
2021
ASL Città di Torino
Calcagno A; Di Perri G; Boglione L; Bonora S; Ghisetti V; Allice T; Trunfio M; Burdino E;
Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2021 Dec;87(12):4861-4867. doi: 10.1111/bcp.14895. Epub 2021 Jul 4.
2021
ASL Città di Torino
Scabini S; Montrucchio G; De Nicolò A; Corcione S; Avataneo V; Bonetto C; Mornese Pinna S; Cusato J; Canta F; Urbino R; Di Perri G; Brazzi L; De Rosa FG; D'Avolio A;
Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. in American journal of obstetrics and gynecology / Am J Obstet Gynecol. 2021 Apr;224(4):391.e1-391.e7. doi: 10.1016/j.ajog.2020.10.005. Epub 2020 Oct 8
2021
AOU Città della Salute di Torino
ASL Città di Torino
Benedetto C; Di Perri G; Ghisetti V; D'Avolio A; Filippini C; Bovetti M; Carosso M; Borella F; Cosma S; Carosso AR; Cusato J;
Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery. in Journal of reproductive immunology / J Reprod Immunol. 2021 Apr;144:103285. doi: 10.1016/j.jri.2021.103285. Epub 2021 Feb 2.
2021
AOU Città della Salute di Torino
ASL Città di Torino
Di Perri G; Benedetto C; Preti M; Ghisetti V; Borella F; Antonucci M; Marozio L; Revelli A; Corcione S; Cusato J; Carosso AR; Cosma S;
Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what matters. in PloS one / PLoS One. 2021 Aug 5;16(8):e0254875. doi: 10.1371/journal.pone.0254875. eCollection 2021.
2021
AOU Città della Salute di Torino
ASL Città di Torino
Benedetto C; Ghisetti V; Di Perri G; Preti M; Stura I; Gervasoni F; Carosso AR; Cusato J; Borella F; Carosso M; Cosma S;
Alzheimer Dementia in People Living With HIV in Neurology: Clinical Practice
2021
ASL Città di Torino
Di Perri G; Trunfio M; Orofino G; Imperiale D; Atzori C; Arena V; D'ettorre G; Guaraldi G; Gisslen M; Calcagno A; Celani L;
Prenatal biochemical and ultrasound markers in covid-19 pregnant patients: A prospective case-control study in Diagnostics
2021
AOU Città della Salute di Torino
ASL Città di Torino
Benedetto C; Di Perri G; Ghisetti V; Filippini C; Rolfo A; Revelli A; Marozio L; Sciarrone A; Gervasoni F; Carosso M; Bevilacqua F; Bovetti M; Cusato J; Borella F; Carosso AR; Cosma S;
Risk for SARS-CoV-2 infection in healthcare workers, Turin, Italy in Emerging Infectious Diseases
2021
ASL Città di Torino
Lipani F; Nigra M; D'Avolio A; Bonora S; Di Perri G; Calcagno A; Ghisetti V; Emanuele T; Trunfio M; Faraoni S; Boglione L; Burdino E; Audagnotto S;
Blood–brain barrier impairment in patients living with hiv: Predictors and associated biomarkers in Diagnostics
2021
ASL Città di Torino
Nigra M; Atzori C; Imperiale D; Bonora S; Di Perri G; Calcagno A; Caligaris G; Trunfio M; Ghisetti V; Cusato J;
The use of less neurotoxic antiretrovirals: Secondary endpoints of the Marand-X study in Topics in Antiviral Medicine
2021
ASL Città di Torino
Bonora S; Di Perri G; Mighetto L; Marinaro L; Trunfio M; Noce G; Atzori C; Guastamacchia G; Stroffolini G; Barco A; Orlando S; Pirriatore V; Calcagno A;
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases. in Frontiers in microbiology / Front Microbiol. 2021 Mar 16;12:646679. doi: 10.3389/fmicb.2021.646679. eCollection 2021.
2021
ASL Città di Torino
Longo BM; Trunfio M; Alladio F; Venuti F; Cerutti F; Ghisetti V; Bonora S; Di Perri G; Calcagno A;
The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIV in Expert Opinion on Drug Metabolism and Toxicology
2021
ASL Città di Torino
Trunfio M; Calcagno A; D’Avolio A; Di Perri G; Bonora S;
2021
ASL Città di Torino
AOU Città della Salute di Torino
De Rosa FG; D'Avolio A; Stella M; Di Perri G; Romeo MR; Corgiat Loia R; Pensa A; Segala FV; Lupia T; De Nicolò A; Corcione S;
Low tenofovir plasma exposure in HIV oral pre-exposure prophylaxis recipients with gastrointestinal disorders in Antimicrobial Agents and Chemotherapy
2021
ASL Città di Torino
D'Avolio A; Di Perri G; Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S;
Antiviral Therapy in Patients With Hepatitis B Virus Treated for Tuberculosis: A Forgotten Issue. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2020 Sep 12;71(6):1583-1584. doi: 10.1093/cid/ciz1199.
2020
ASL Città di Torino
Lipani F; Boglione L; Lucchini AM; Salvador E; De Benedetto I; Lupia T; Di Perri G;
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV. in AIDS (London, England) / AIDS. 2020 Nov 1;34(13):1899-1906. doi: 10.1097/QAD.0000000000002601.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Guastamacchia G; Vai D; Atzori C; Trunfio M; Borgogno E; Domini S; Nigra M; Mighetto L; Rugge W;
Beyond Italian guidelines in the management of HIV-positive patient. in Le infezioni in medicina / Infez Med. 2020 Nov 1;28(4):587-596.
2020
ASL Città di Torino
Mussini C; Gori A; Galli M; D'Arminio Monforte A; Di Perri G; Castagna A; Antinori A; Andreoni M; Perno CF;
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino
Roccatello D; Oddone V; Osella S; Piccioni P; Radin M; Navarra M; Natale G; Milone V; Massara C; Manno E; Livigni S; Giusti M; Imperiale D; Imperiale G; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Cozzi M; Converso M; Cinnirella G; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Baldovino S; Rossi D; et alii...
Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation. in AIDS (London, England) / AIDS. 2020 Mar 1;34(3):373-380. doi: 10.1097/QAD.0000000000002442.
2020
ASL Città di Torino
Calcagno A; Bonora S; Di Perri G; Ghisetti V; Lipani F; Gregori G; Pirriatore V; Gianella S; Mighetto L; Imperiale D; Audagnotto S; Milia MG; Atzori C; Lupia T;
Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment? in Journal of global antimicrobial resistance / J Glob Antimicrob Resist. 2020 Mar;20:22-27. doi: 10.1016/j.jgar.2019.06.011. Epub 2019 Jun 14.
2020
ASL Città di Torino
De Rosa FG; Stella M; Di Perri G; De Nicolò A; Romeo M; Fatiguso G; Segala FV; Corcione S; D'Avolio A; Pensa A; Loia RC;
Calcaneal Quantitative Ultrasonography and Urinary Retinol-Binding Protein in Antiretroviral-Treated Patients With Human Immunodeficiency Virus in Uganda: A Pilot Study. in The Journal of infectious diseases / J Infect Dis. 2020 Jun 29;222(2):263-272. doi: 10.1093/infdis/jiaa088.
2020
ASL Città di Torino
Castelnuovo B; Di Perri G; Lamorde M; Calcagno A; Cusato J; Kafufu B; Borderi M; Mwaka E; Kasozi W; Scabini S; Kaimal A; Costa C;
Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study. in CNS spectrums / CNS Spectr. 2020 Jun;25(3):402-408. doi: 10.1017/S1092852919000981. Epub 2019 May 27.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Burdino E; Audagnotto S; Mighetto L; Milia MG; Lipani F; Imperiale D; Atzori C; Alcantarini C; Di Stefano A;
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2020 Jul 1;75(7):1772-1777. doi: 10.1093/jac/dkaa152.
2020
ASL Città di Torino
de Nicolò A; Avataneo V; Cusato J; Antonucci M; Manca A; Palermiti A; Waitt C; Walimbwa S; Lamorde M; di Perri G; D'Avolio A;
Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders. in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy / J Infect Chemother. 2020 Jan;26(1):18-22. doi: 10.1016/j.jiac.2019.06.004. Epub 2019 Jul 10.
2020
ASL Città di Torino
Boglione L; Lupia T; Cariti G; Di Perri G;
Cerebral white matter Hyperintensities in HIV-positive patients. in Brain imaging and behavior / Brain Imaging Behav. 2020 Feb;14(1):10-18. doi: 10.1007/s11682-018-9966-1.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Barco A; Nunnari G; Imperiale D; Cusato J; Tettoni M; Trentalange A; Prochet A;
Plasmatic and intracellular concentration of entecavir during treatment of a symptomatic flare in HBV-HDV decompensated cirrhosis. in Journal of infection and public health / J Infect Public Health. 2020 Feb;13(2):315-316. doi: 10.1016/j.jiph.2019.12.005. Epub 2020 Jan 15.
2020
ASL Città di Torino
Boglione L; De Benedetto I; Salvador E; Lupia T; De Nicolò A; Di Perri G; Lipani F; Lucchini AM;
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.
2020
ASL Città di Torino
Ferrara M; Ianniello A; De Nicolò A; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;
Tenofovir alafenamide revisited. in Le infezioni in medicina / Infez Med. 2020 Dec 1;28(4):525-533.
2020
ASL Città di Torino
Di Perri G;
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. in Thrombosis research / Thromb Res. 2020 Dec;196:432-434. doi: 10.1016/j.thromres.2020.09.039. Epub 2020 Oct 8.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Roccatello D; Lipani F; Sciascia S; Trentalange A; Gaviraghi A; Alcantarini C; Marinaro L; Cabodi D; Salvador E; Trunfio M;
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients. in The pharmacogenomics journal / Pharmacogenomics J. 2020 Apr;20(2):202-212. doi: 10.1038/s41397-019-0109-x. Epub 2019 Oct 16.
2020
ASL Città di Torino
Calcagno A; Cusato J; Marinaro L; Avataneo V; Di Perri G; Bonora S;
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation in International Journal of Antimicrobial Agents
2020
ASL Città di Torino
Calcagno A; Di Perri G; Celani L; Bonora S; D'Avolio A; Tettoni M; Lazzaro A; D'Ascenzo F; D'Ettorre G; De Nicolò A; Montrucchio C;
Vitamin D plasma level can affect nivolumab drug exposure in a cohort of patients with non-small-cell lung cancer in Biochimica Clinica
2020
ASL Città di Torino
D’Avolio A; Grossi F; Ferlazzo G; Boccardo S; Coco S; Dal Bello MG; Di Perri G; Leggieri A; Cossu I; Rijavec E; Mingari MC; Pietra G; Ottonello S; Carrega P; Genova C; Tomasello C; Cusato J;
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity. in Antiviral therapy / Antivir Ther. 2020;25(6):327-333. doi: 10.3851/IMP3377.
2020
ASL Città di Torino
Gaviraghi A; Salvador E; Trunfio M; Audagnotto S; Marinaro L; Motta I; Casciaro R; Ghisetti V; Fava C; Bonora S; Di Perri G; Calcagno A;
Pharmacogenetic markers able to predict lipid-related parameters in a cohort of ritonavir treated patients in Biochimica Clinica
2020
ASL Città di Torino
Palermiti A; Marinaro L; Avataneo V; De Nicolò A; D'Avolio A; Bonora S; Di Perri G; Cusato J; Calcagno A; Antonucci M;
Drug-drug interactions in anti-HCV therapy: a comparison among options available in Italy. in Le infezioni in medicina / Infez Med. 2019 Sep 1;27(3):239-250.
2019
ASL Città di Torino
Di Perri G; Cariti G;
HIV-1 detection in the olfactory mucosa of HIV-1-infected participants. in AIDS (London, England) / AIDS. 2019 Mar 15;33(4):665-674. doi: 10.1097/QAD.0000000000002102.
2019
ASL Città di Torino
Calcagno A; Zanusso G; Bonora S; Di Perri G; Pirriatore V; Amasio E; Ghisetti V; Cassoni P; Kincer LP; Catera S; Imperiale D; Allice T; Trunfio M; Joseph SB; Bertero L;
Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20
2019
ASL Città di Torino
Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;
Antiviral treatment with pegylated interferon and clinical outcomes in a cohort of immigrants patients affected by hepatitis delta: A retrospective analysis. in Journal of medical virology / J Med Virol. 2019 Jul;91(7):1329-1334. doi: 10.1002/jmv.25438. Epub 2019 Mar 4.
2019
ASL Città di Torino
Boglione L; Lupia T; Cariti G; Ghisetti V; Milia MG; Burdino E; Di Perri G;
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab. in Cancers / Cancers (Basel). 2019 Jan 21;11(1):125. doi: 10.3390/cancers11010125.
2019
ASL Città di Torino
Grossi F; Ferlazzo G; Boccardo S; Coco S; Di Perri G; Dal Bello MG; Leggieri A; Rijavec E; Cossu I; Mingari MC; Ottonello S; Pietra G; Carrega P; Genova C; Tomasello C; D'Avolio A; Cusato J;
Clinical pharmacology of the single tablet regimen bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF). in Le infezioni in medicina / Infez Med. 2019 Dec 1;27(4):365-373.
2019
ASL Città di Torino
Di Perri G;
ERRATUM Drug-drug interactions in anti-HCV therapy: a comparison among options available in Italy. in Le infezioni in medicina / Infez Med. 2019 Dec 1;27(4):481.
2019
ASL Città di Torino
Di Perri G; Cariti G;
The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes. in Journal of neurovirology / J Neurovirol. 2019 Dec;25(6):887-892. doi: 10.1007/s13365-019-00769-4. Epub 2019 Jun 18.
2019
ASL Città di Torino
Di Perri G; Bonora S; Taraglio S; Imperiale D; Audagnotto S; Boghi A; Manini C; Trentalange A; Trunfio M; Calcagno A;
Alzheimer's dementia cerebrospinal fluid biomarkers in hivpositive patients on cart in Topics in Antiviral Medicine
2019
ASL Città di Torino
Trunfio M; Martini C; Mighetto L; Vai D; Imperiale D; Bonora S; Di Perri G; Calcagno A;
Antiretrovirals concentrations in the olfactory mucosa of hivpositive patients in Topics in Antiviral Medicine
2019
ASL Città di Torino
Calcagno A; De Nicolò A; Trunfio M; Allice T; Imperiale D; Bartoli C; Ghisetti V; Amasio ME; D'Avolio A; Di Perri G; Bonora S;
Impact of pharmacogenetic on voriconazole plasma concentration in patients with invasive fungal disease in European Journal of Human Genetics
2019
ASL Città di Torino
D'Avolio A; Di Perri G; Favata F; Arduino A; De Francia S; Fatiguso G; Allegra S;
Influence of Vitamin D in advanced non-small cell lung cancer patients treated with nivolumab in Cancers
2019
ASL Città di Torino
D’Avolio A; Grossi F; Ferlazzo G; Boccardo S; Coco S; Dal Bello MG; Di Perri G; Leggieri A; Rijavec E; Cossu I; Mingari MC; Pietra G; Ottonello S; Carrega P; Tomasello C; Genova C; Cusato J;
Malignant Melanoma in People Living with HIV/AIDS: Can We Know More, Can We Do Better? in AIDS reviews / AIDS Rev. 2019;21(2):65-75. doi: 10.24875/AIDSRev.19000038.
2019
ASL Città di Torino
Trunfio M; Ribero S; Bonora S; Di Perri G; Quaglino P; Calcagno A;
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort. in PloS one / PLoS One. 2019 Oct 17;14(10):e0222225. doi: 10.1371/journal.pone.0222225. eCollection 2019.
2019
ASL Città di Torino
Focà E; Magro P; Guaraldi G; Riva A; Cattelan AM; De Socio GV; Costa C; Piconi S; Celesia BM; Nozza S; Orofino G; Castagna A; Di Perri G; Castelli F; Calcagno A;
Flecainide plasma level modifications during ledipasvir/sofosbuvir coadministration in two patients affected by chronic hepatitis C. in Antiviral therapy / Antivir Ther. 2019;24(7):553-555. doi: 10.3851/IMP3328.
2019
ASL Città di Torino
Boglione L; De Nicolò A; Di Perri G; D'Avolio A;
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples. in Journal of pharmacological and toxicological methods / J Pharmacol Toxicol Methods. 2018 Nov-Dec;94(Pt 2):29-35. doi: 10.1016/j.vascn.2018.08.003. Epub 201
2018
AOU Città della Salute di Torino
ASL Città di Torino
Di Perri G; Veglio F; Mulatero P; Favata F; Allegra S; Fatiguso G; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A;
Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Nov;84(11):2535-2543. doi: 10.1111/bcp.13706. Epub 2018 Aug 15.
2018
AOU Città della Salute di Torino
ASL Città di Torino
D'Avolio A; Cusato J; Pappaccogli M; Berra E; Burrello J; Perlo E; Rabbia F; De Nicolò A; Avataneo V; Di Perri G; Veglio F;
Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders. in HIV medicine / HIV Med. 2018 May 15. doi: 10.1111/hiv.12622.
2018
ASL Città di Torino
Di Perri G; Bonora S; Imperiale D; Audagnotto S; Orofino G; Tettoni MC; Livelli A; Alcantarini C; Vai D; Montrucchio C; Trunfio M; Calcagno A;
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2018 Mar;81(3):615-620. doi: 10.1007/s00280-018-3520-0. Epub 2018 Jan 22
2018
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathy. in Le infezioni in medicina / Infez Med. 2018 Jun 1;26(2):160-163.
2018
ASL Città di Torino
Di Perri G; Calcagno A; Cistaro A; Perna M; Cinnirella G; Ghisetti V; Audagnotto S; Bertucci R; Imperiale D; Pirriatore V; Trunfio M; Scabini S;
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jun 1;73(6):1659-1664. doi: 10.1093/jac/dky053.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy. in Pharmacogenomics / Pharmacogenomics. 2018 Jun 1;19(8):701-707. doi: 10.2217/pgs-2018-0009. Epub 2018 May 23.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Pinna SM; Carcieri C; Guido F; Cariti G; Di Perri G; D'Avolio A;
Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis. in Journal of medical virology / J Med Virol. 2018 Jun;90(6):1047-1052. doi: 10.1002/jmv.25038. Epub 2018 Mar 15.
2018
ASL Città di Torino
Boglione L; Cariti G; Ghisetti V; Burdino E; Di Perri G;
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2018 Jun;60:42-47. doi: 10.1016/j.meegid.2018.02.016. Epub 2018 Feb 13.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;
Cannabinoids concentration variability in cannabis olive oil galenic preparations. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2018 Jan;70(1):143-149. doi: 10.1111/jphp.12845. Epub 2017 Oct 23.
2018
ASL Città di Torino
D'Avolio A; Di Perri G; Canzoneri L; Cusato J; Avataneo V; De Nicolò A; Simiele M; Tomasello C; Carcieri C;
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.
2018
ASL Città di Torino
Cusato J; Carcieri C; De Nicolò A; Di Perri G; D'Avolio A; Allegra S; Fatiguso G; Pirro E; Favata F; De Francia S;
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infections. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Feb 1;73(2):546-548. doi: 10.1093/jac/dkx385.
2018
ASL Città di Torino
Motta I; Trunfio M; Calcagno A; Pirriatore V; Scabini S; Palazzo A; Audagnotto S; Fatiguso G; Liberini V; Bellò M; D'Avolio A; Di Perri G; Bonora S;
Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia. in Journal of neurovirology / J Neurovirol. 2018 Feb;24(1):132-136. doi: 10.1007/s13365-017-0605-1. Epub 2017 Dec 14.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
Di Perri G; Imperiale D; Sala A; Ferrara M; Pesci Kincer L; Audagnotto S; Cusato J; Martini C; Romito A; Ghisetti V; Joseph SB; Trunfio M; Calcagno A;
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.
2018
ASL Città di Torino
Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years. in BMC geriatrics / BMC Geriatr. 2018 Apr 20;18(1):99. doi: 10.1186/s12877-018-0789-0.
2018
ASL Città di Torino
Guaraldi G; Malagoli A; Calcagno A; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Riva A; Focà E; Nozza S; Di Perri G;
Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment. in The new microbiologica / New Microbiol. 2018 Apr;41(2):112-117.
2018
ASL Città di Torino
AOU Città della Salute di Torino
Acone B; Calza L; Rizzardini G; Quirino T; Viale P; Perno CF; Lazzarin A; Mussini C; Galli M; Gori A; Di Perri G; Di Biagio A; Cinque P; D'Arminio Monforte A; Chirianni A; Antinori A; Angarano G; Borderi M; Andreoni M;
Current and future challenges in HCV: insights from an Italian experts panel. in Infection / Infection. 2018 Apr;46(2):147-163. doi: 10.1007/s15010-017-1093-1. Epub 2017 Nov 2.
2018
ASL Città di Torino
Andreoni M; Babudieri S; Bruno S; Colombo M; Zignego AL; Di Marco V; Di Perri G; Perno CF; Puoti M; Taliani G; Villa E; Craxì A;
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens. in Archives of virology / Arch Virol. 2018 Apr;163(4):961-967. doi: 10.1007/s00705-017-3684-7. Epub 2018 Jan 9.
2018
ASL Città di Torino
Boglione L; Cusato J; Pinna SM; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Laboratory findings in Zika infection: The experience of a reference centre in North-West Italy. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2018 Apr;101:18-22. doi: 10.1016/j.jcv.2018.01.010. Epub 2018 Jan 31.
2018
ASL Città di Torino
Burdino E; Milia MG; Allice T; Gregori G; Ruggiero T; Calleri G; Lipani F; Lucchini A; Venturi G; Di Perri G; Ghisetti V;
The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment. in Antiviral therapy / Antivir Ther. 2018;23(5):451-456. doi: 10.3851/IMP3221.
2018
ASL Città di Torino
Montrucchio C; Audagnotto S; Lucchini A; Calcagno A; Bigliano P; Marinaro L; Alcantarini C; Ghisetti V; Di Perri G; Bonora S;
HIV-RNA in the olfactory mucosa of HIV-positive patients in Topics in Antiviral Medicine
2018
ASL Città di Torino
Trunfio M; Allice T; Bertero L; Imperiale D; Catera S; Pirriatore V; Di Perri G; Amasio ME; Cassoni P; Ghisetti V; Bonora S; Calcagno A;
Vitamin D plasma level is able to affect nivolumab drug exposure in a cohort of patients with non small cell lung cancer in Biochimica Clinica
2018
ASL Città di Torino
D'Avolio A; Di Perri G; Grossi F; Ferlazzo G; Mingari MC; Cossu I; Pietra G; Ottonello S; Tomasello C; Genova C; Carrega P; Cusato J;
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. in PloS one / PLoS One. 2018 Feb 20;13(2):e0192627. doi: 10.1371/journal.pone.0192627. eCollection 2018.
2018
ASL Città di Torino
AOU Città della Salute di Torino
Segala D; Teti E; Taramasso L; Di Biagio A; Bovis F; Nicolini LA; Antinori A; Milazzo L; Chirianni A; Vullo V; Parruti G; Giacometti A; Cacopardo B; Boffa N; Gori A; Spinetti A; Puoti M; Pasquazzi C; Di Perri G; Mastroianni C; Bruno R; Borghi V; Montagnani F; Cattelan A; Hasson H; Taliani G; D'Arminio Monforte A; Bigoni S; Saracino A; et alii...
Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B. in Antiviral therapy / Antivir Ther. 2018;23(4):373-377. doi: 10.3851/IMP3207.
2018
ASL Città di Torino
De Nicolò A; Boglione L; Cusato J; Fatiguso G; Favata F; Allegra S; Cariti G; Di Perri G; D'Avolio A;
Retreatment with sofosbuvir/velpatasvir in cirrhotic patients with genotype-4 who failed a previous interferon-free regimen: a case series. in Antiviral therapy / Antivir Ther. 2018;23(6):543-547. doi: 10.3851/IMP3226.
2018
ASL Città di Torino
Boglione L; Pinna SM; Lupia T; Cariti G; Di Perri G;
The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Sep;44(9):965-968. doi: 10.1111/1440-1681.12786.
2017
ASL Città di Torino
El Desoky ES; Abdelhafez AT; Cusato J; Kamel SI; Hussein AM; De Nicolo A; Di Perri G; D'Avolio A;
Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Sep;53:195-198. doi: 10.1016/j.meegid.2017.05.026. Epub 2017 Jun 1.
2017
ASL Città di Torino
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;
A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Oct 25;145:718-724. doi: 10.1016/j.jpba.2017.07.040. Epub 2017 Aug 5.
2017
ASL Città di Torino
Fatiguso G; Favata F; Zedda I; De Nicolò A; Cusato J; Avataneo V; Di Perri G; D'Avolio A;
Reasons to wait or to treat naive patients affected by chronic hepatitis C with low fibrosis stage and genotypes 2 or 3. in European journal of public health / Eur J Public Health. 2017 Oct 1;27(5):938-941. doi: 10.1093/eurpub/ckx025.
2017
ASL Città di Torino
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Influence of ABCB11 and HNF4? genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2846-2849. doi: 10.1093/jac/dkx237.
2017
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy? in Journal of neurovirology / J Neurovirol. 2017 Oct;23(5):763-767. doi: 10.1007/s13365-017-0549-5. Epub 2017 Jul 5.
2017
ASL Città di Torino
Di Perri G; Bonora S; Lipani F; Prochet A; Ghisetti V; Audagnotto S; Imperiale D; Milia MG; Scarvaglieri E; Mornese Pinna S; Calcagno A;
Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study. in Journal of viral hepatitis / J Viral Hepat. 2017 Oct;24(10):850-857. doi: 10.1111/jvh.12711. Epub 2017 Apr 25.
2017
ASL Città di Torino
Boglione L; Mornese Pinna S; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.
2017
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; De Nicolò A; Di Perri G; Cusato J; Pirro E; Carcieri C; Favata F; De Francia S; Fatiguso G; Allegra S;
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5
2017
ASL Città di Torino
D'Avolio A; Cusato J; Di Perri G; De Nicolò A; De Francia S; Carcieri C; Pirro E; Favata F; Fatiguso G; Allegra S;
UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 May 10;138:223-230. doi: 10.1016/j.jpba.2017.02.002. Epub 2017 Feb 3.
2017
ASL Città di Torino
Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A;
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):607-611. doi: 10.2217/pgs-2016-0040. Epub 2017 Apr 28.
2017
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):651-661. doi: 10.2217/pgs-2016-0041. Epub 2017 Apr 28.
2017
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Imbornone R; Cardellino CS; Ghisetti V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2017 Mar 1;64(5):680-683. doi: 10.1093/cid/ciw846. Epub 2016 Dec 22.
2017
ASL Città di Torino
AOU Città della Salute di Torino
Massimo A; Teti E; Pasquazzi C; Pennica A; Chirianni A; Vullo V; Parruti G; Giacometti A; Bruno C; Boffa N; Gori A; Spinetti A; Puoti M; Bigoni S; Di Perri G; Mastroianni CM; Monforte AD; Taliani G; Hasson H; Cattelan A; De Luca A; Borghi V; Saracino A; Bruno R; Di Biagio A; Rizzardini G; Sollima S; Milazzoi L; Antinori A; et alii...
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2017 Mar;12(1):187-193. doi: 10.1007/s11481-016-9717-2. Epub 2016 Nov 8.
2017
ASL Città di Torino
Di Perri G; Imperiale D; Lipani F; Scarvaglieri E; Audagnotto S; Cardellino C; Ghisetti V; Atzori C; Romito A; Calcagno A; Bonora S;
First UHPLC-MS/MS method coupled with automated online SPE for quantification both of tacrolimus and everolimus in peripheral blood mononuclear cells and its application on samples from co-treated pediatric patients. in Journal of mass spectrometry : JMS / J Mass Spectrom. 2017 Mar;52(3):187-195. doi: 10.1002/jms.3909.
2017
AOU Città della Salute di Torino
ASL Città di Torino
Tandoi F; Romagnoli R; Nonnato A; Calvo PL; Pisciotta C; De Nicolò A; Pinon M; Pensi D; Di Perri G; D'Avolio A;
Pharmacokinetics of linezolid in critically ill patients: impact of continuous venovenous haemofiltration. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2017 Jun;49(6):784-785. doi: 10.1016/j.ijantimicag.2017.04.002. Epub 2017 A
2017
ASL Città di Torino
AOU Città della Salute di Torino
Di Perri G; Ranieri MV; Urbino R; Allegra S; Fanelli V; D'Avolio A; Corcione S; De Rosa FG;
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. in Pharmacogenomics / Pharmacogenomics. 2017 Jun;18(9):865-880. doi: 10.2217/pgs-2017-0176. Epub 2017 Jun 8.
2017
ASL Città di Torino
Allegra S; Fatiguso G; Calcagno A; Baietto L; Motta I; Favata F; Cusato J; Bonora S; Di Perri G; D'Avolio A;
Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2017 Jun;49(6):705-708. doi: 10.1016/j.dld.2017.01.144. Epub 2017 Jan 17.
2017
ASL Città di Torino
Boglione L; De Nicolò A; Mornese Pinna S; Cusato J; Favata F; Ariaudo A; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Jul;51:167-172. doi: 10.1016/j.meegid.2017.03.014. Epub 2017 Mar 16.
2017
ASL Città di Torino
Boglione L; Cardellino CS; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Jan;72(1):319-321. doi: 10.1093/jac/dkw361. Epub 2016 Sep 2.
2017
ASL Città di Torino
AOU Città della Salute di Torino
D'Avolio A; Di Perri G; Stella M; Malvasio V; Baietto L; Corcione S; De Rosa FG;
Treating HIV Infection in the Central Nervous System. in Drugs / Drugs. 2017 Feb;77(2):145-157. doi: 10.1007/s40265-016-0678-9.
2017
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S;
Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2017 Feb;87:30-36. doi: 10.1016/j.jcv.2016.11.015. Epub 2016 Dec 1.
2017
ASL Città di Torino
Marinaro L; Calcagno A; Ripamonti D; Cenderello G; Pirriatore V; Trentini L; Salassa B; Bramato C; Orofino G; D'Avolio A; Rizzi M; Di Perri G; Rusconi S; Bonora S;
Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors. in Infection / Infection. 2017 Feb;45(1):103-106. doi: 10.1007/s15010-016-0962-3. Epub 2016 Nov 16.
2017
ASL Città di Torino
Boglione L; Pinna SM; Cardellino CS; De Nicolò A; Cusato J; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Aug 5;142:279-285. doi: 10.1016/j.jpba.2017.05.018. Epub 2017 May 13.
2017
AOU Città della Salute di Torino
ASL Città di Torino
D'Avolio A; Di Perri G; Veglio F; Mulatero P; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; De Nicolò A; Avataneo V;
Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia. in Antiviral therapy / Antivir Ther. 2017;22(6):539-543. doi: 10.3851/IMP3140. Epub 2017 Feb 15.
2017
ASL Città di Torino
Bonora S; Di Perri G; Ghisetti V; Imperiale D; Ecclesia S; Ferrara M; Romito A; Allice T; Motta I; Calcagno A;
High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders. in Current HIV research / Curr HIV Res. 2017;15(4):258-265. doi: 10.2174/1570162X15666170531085838.
2017
ASL Città di Torino
Sordella F; Bracchi M; Balbiano R; Caracciolo D; Lucchini A; Calcagno A; Gregori G; Lipani F; Audagnotto S; Chiriotto M; Cavaglia G; Ghisetti V; Di Perri G; Bonora S;
Additional screening tests for HIV-associated neurocognitive disorders in Topics in Antiviral Medicine
2017
ASL Città di Torino
Trunfio M; Montrucchio C; Vai D; Imperiale D; Livelli A; Orofino G; Trentalange A; Bonora S; Di Perri G; Calcagno A;
Discordant HIV RNA in olfactory mucosa of HIV-positive patients in Topics in Antiviral Medicine
2017
ASL Città di Torino
Calcagno A; Allice T; Bertero L; Trunfio M; Amasio ME; Imperiale D; Ghisetti V; Di Perri G; Cassoni P; Bonora S;
UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jan 25;118:64-69. doi: 10.1016/j.jpba.2015.10.017. Epub 2015 Oct 22.
2016
ASL Città di Torino
Di Perri G; Tomasello C; Pensi D; Cusato J; Boglione L; Bonifacio G; De Nicolò A; D'Avolio A;
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients. in Journal of neurovirology / J Neurovirol. 2016 Feb;22(1):88-92. doi: 10.1007/s13365-015-0371-x. Epub 2015 Aug 6.
2016
ASL Città di Torino
Di Perri G; Imperiale D; Montrucchio C; Stella ML; Audagnotto S; Vai D; Atzori C; Romito A; Calcagno A; Bonora S;
Efavirenz pharmacogenetics in a cohort of Italian patients. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Feb;47(2):117-23. doi: 10.1016/j.ijantimicag.2015.11.012. Epub 2015 De
2016
ASL Città di Torino
Di Perri G; Leggieri A; Allegra S; Marinaro L; Bonora S; Calcagno A; Simiele M; Tomasello C; Cusato J; D'Avolio A;
Cerebrospinal fluid and plasma biomarkers in patients with HIV-associated neurocognitive disorders in Journal of the International AIDS Society
2016
ASL Città di Torino
Trunfio M; Vai D; Romito A; Atzori C; Imperiale D; Audagnotto S; Montrucchio C; Scabini S; Cardellino C; Pirriatore V; Di Perri G; Bonora S; Calcagno A;
In Vitro Stabilifighty Evaluation of Different Pharmaceutical Products Containing Meropenem. in Hospital pharmacy / Hosp Pharm. 2015 Apr;50(4):296-303. doi: 10.1310/hpj5004-296. Epub 2015 Apr 8.
2015
ASL Città di Torino
D'Avolio A; Di Perri G; Cavalli R; Leggieri A; Tomasello C;
Combination of conventional blood cultures and the SeptiFast molecular test in patients with suspected sepsis for the identification of bloodstream pathogens. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2014 Jul;79(3):287-92. doi: 10.1016/j.diagmicrobio.2014.03.018. Epub 201
2014
ASL Città di Torino
Caramello P; Di Perri G; Manno E; De Rosa FG; Cerutti F; Milano R; Gregori G; Milia MG; Allice T; Ruggiero T; Burdino E; Ghisetti V;
Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19719. doi: 10.7448/IAS.17.4.19719. eCollection 2014.
2014
ASL Città di Torino
Di Perri G; Trentalange A; Alberione MC; Audagnotto S; Imperiale D; Ecclesia S; Romito A; Atzori C; Calcagno A; Bonora S;
Prevalence and predictors of blood-brain barrier damage in the HAART era in Journal of NeuroVirology
2014
ASL Città di Torino
Calcagno A; Alberione MC; Romito A; Imperiale D; Ghisetti V; Audagnotto S; Lipani F; Raviolo S; Di Perri G; Bonora S;
2011
ASL Città di Torino
Calcagno A; Bonora S; Simiele M; Rostagno R; Tettoni MC; Bonasso M; Romito A; Imperiale D; D'Avolio A; Di Perri G;
Tenofovir and emtricitabine CSF-to-plasma ratios correlate to the extent of blood-brain-barrier damage in Infection
2011
ASL Città di Torino
Calcagno A; Bonora S; Simiele M; Audagnotto S; Siccardi M; De Requena DG; Romito A; Imperiale D; D'Avolio A; Di Perri G;
Human trafficking: Social, medical and infectological aspects in Giornale Italiano di Medicina Tropicale
2011
ASL Città di Torino
Dal Conte I; Di Perri G;
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism in Pharmacogenetics and Genomics
2010
ASL Città di Torino
Siccardi M; D'Avolio A; Nozza S; Simiele M; Baietto L; Stefani FR; Moss D; Kwan W-S; Castagna A; Lazzarin A; Calcagno A; Bonora S; Back D; Di Perri G; Owen A;
Infective endocarditis in intravenous drug users from Italy: The increasing importance in HIV-infected patients in Infection
2007
ASL Città di Torino
De Rosa FG; Cicalini S; Canta F; Audagnotto S; Cecchi E; Di Perri G;
Are the Duke criteria really useful for the early bedside diagnosis of infective endocarditis? Results of a prospective multicenter trial in Italian Heart Journal
2005
ASL Città di Torino
ASL Cuneo 1
Cecchi E; Trinchero R; Imazio M; Forno D; Dal Conte I; Lipani F; Brusca A; Gnavi R; Bobbio M; Di Perri G; Caramello P; Veglio V; Soranzo ML; Mangiardi L; Commodo E; Trevi GP; Tidu M; Chinaglia A; Pomari F; Demichelis B; Biancochinto F; Preziosi C; Ugliengo G; Patrone M; Ricchiardi E; De Ambrogio V; Aloi N; Madama G; Leonardi G; et alii...
New trends in the epidemiological and clinical features of infective endocarditis: Results of a multicenter prospective study in Italian Heart Journal
2004
ASL Cuneo 1
ASL Città di Torino
Moiraghi P; Scaroina F; Quattrocchio G; Anselmino M; Capra A; Cavaliere R; Chiesa A; Bonzano A; Crosazzo C; Cavallo Perin P; Santoro M; Pasquino M; Actisdato G; Forsennati PG; Di Summa M; Bonino G; Schinco P; Pagano GF; Peano P; Emanuelli G; Checco L; Bernasconi C; Calachanis M; Morello M; Mangiardi L; Biancochinto F; Soranzo ML; Preziosi C; Veglio V; et alii...